V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210038912 | 210036188 | 1.79 | 73 | Curative (C) | 2020-02-16 | 2020-02-16 | Cytarabine HD + Methotrexate HD | N | N | 210040628 | CYCLOPHOSPHAMIDE + ETOPOSIDE + NELARABINE |
| 210038913 | 210038852 | 1.21 | 21.9 | Curative (C) | 2019-07-12 | 2020-04-05 | ALL UKALL2011 Del Int C Recon PAsp | Y | N | 210002777 | UKALL2011 |
| 210038914 | 210004981 | null | 64.6 | Curative (C) | 2019-04-22 | 2019-04-22 | ALL UKALL2011 Cap Int Maint C PAsp | Y | null | 210004002 | UKALL2011 |
| 210038917 | 210005762 | 0 | 0 | Curative (C) | 2016-06-03 | 2016-06-03 | ALL UKALL2011 Ind A Sht Dex (PAsp) | N | N | 210007627 | UKALL 2011 |
| 210038918 | 210032843 | 1.11 | 0 | Curative (C) | 2015-06-06 | 2016-05-25 | Methotrexate intrathecal | Y | N | 210007896 | METHOTREXATE INTRATHECAL |
| 210038919 | 210034714 | 0 | 18.4 | Curative (C) | 2014-12-23 | 2014-12-24 | Methotrexate intrathecal | N | null | 210008060 | METHOTREXATE INTRATHECAL |
| 210038920 | 210029999 | 1.05 | 13.2 | null | 2017-07-23 | 2017-10-22 | Methotrexate intrathecal | Y | N | 210008355 | METHOTREXATE INTRATHECAL |
| 210038921 | 210006007 | 0 | 26.1 | Curative (C) | 2017-05-18 | 2017-08-25 | Methotrexate Intrathecal (any age) | Y | N | 210008484 | METHOTREXATE INTRATHECAL |
| 210038923 | 210006339 | 1.52 | 83 | Adjuvant (A) | 2018-01-10 | 2018-01-16 | PCV | N | N | 210009828 | PCV |
| 210038924 | 210006724 | 1.71 | 79.7 | Disease modification (D) | 2016-04-04 | 2016-05-17 | Triple / Double Intrathecal Therapy | N | N | 210010917 | TRIPLE INTRATHECAL |
| 210038925 | 210006766 | 1.8 | null | Curative (C) | 2019-11-26 | 2019-11-29 | BENDAMUSTINE | 02 | N | 210010978 | CARBOPLATIN + ETOPOSIDE |
| 210038927 | 210013420 | 1.59 | 82.3 | Curative (C) | 2019-05-16 | 2020-02-16 | PACLITAXEL | N | null | 210040628 | CYCLO + FLUDARABINE + RITUXIMAB |
| 210038928 | 210004762 | null | 20.6 | Curative (C) | 2020-03-01 | 2020-04-06 | ALL UKALL2011 Del Intens B Pt2 | Y | null | 210002777 | UKALL2011 |
| 210038929 | 210004982 | null | 49.1 | null | 2018-12-02 | 2019-05-27 | ALL UKALL2011 Del Intens B Pt2 | Y | N | 210004002 | UKALL2011 |
| 210038932 | 210005763 | 0 | 17.9 | Curative (C) | 2016-07-02 | 2016-07-02 | ALL UKALL2011 TRIAL | N | N | 210007627 | UKALL 2011 |
| 210038933 | 210005851 | null | 12.35 | Curative (C) | 2016-05-25 | 2016-05-25 | Methotrexate intrathecal | 02 | N | 210007896 | METHOTREXATE INTRATHECAL |
| 210038934 | 210005889 | 1.71 | 85 | Curative (C) | 2014-07-13 | 2015-01-14 | UKALL14- Maintenance | Y | N | 210008060 | UKALL2014 |
| 210038935 | 210029999 | 1.72 | 95 | Curative (C) | 2017-08-14 | 2017-11-20 | UKALL14- Cons Cycle 3 | N | N | 210008355 | UKALL2014 |
| 210038936 | 210032911 | null | null | Curative (C) | 2017-01-26 | 2017-11-23 | CNS Medbl HR Cyclo+Vinc | N | null | 210008484 | TRIAL |
| 210038938 | 210006724 | 1.65 | 69.3 | Disease modification (D) | 2016-12-03 | 2017-02-26 | IDELALISIB + RITUXIMAB | N | N | 210010917 | IDELALISIB + RITUXIMAB |
| 210038939 | 210006767 | 1.71 | 80.6 | Curative (C) | 2019-05-17 | 2019-12-08 | CHOP R - 14 days | N | N | 210010978 | CHOP R |
| 210038941 | 210004763 | null | 19.9 | Curative (C) | 2020-04-13 | 2020-05-30 | ALL UKALL2011 Std Int Maint A | Y | null | 210002777 | UKALL2011 |
| 210038942 | 210004983 | 0.88 | 15.9 | Curative (C) | 2019-03-03 | 2019-08-02 | ALL UKALL2011 Del Int B Pt1 (PAsp) | Y | N | 210004002 | UKALL2011 |
| 210038945 | 210017930 | 1.12 | 37.8 | null | 2016-07-23 | 2016-07-30 | ALL UKALL2011 Consolidation A | Y | N | 210007627 | UKALL 2011 |
| 210038946 | 210005852 | 1.76 | 97.5 | Curative (C) | 2016-05-02 | 2016-08-01 | Trial Unspecified | N | null | 210007896 | TRIAL |
| 210038947 | 210005889 | 1.62 | 75 | Palliative (P) | 2015-02-17 | 2015-04-08 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 210008060 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210038948 | 210032911 | 1.56 | null | Curative (C) | 2017-12-05 | 2017-12-05 | Venetoclax | N | N | 210008484 | VENETOCLAX |
| 210038949 | 210006725 | 1.67 | 26.4 | Palliative (P) | 2016-11-09 | 2017-02-26 | Pentostatin | N | N | 210010917 | CHOP |
| 210038951 | 210004763 | 1.21 | null | Curative (C) | 2020-06-06 | 2020-07-04 | ALL UKALL2011 Del Intens B Pt2 | Y | N | 210002777 | UKALL2011 |
| 210038952 | 210017531 | null | 22.1 | Curative (C) | 2019-08-04 | 2019-11-24 | ALL UKALL2011 (ProtM-A) C PegAsp | Y | null | 210004002 | UKALL2011 |
| 210038955 | 210017930 | 0 | 45.6 | Curative (C) | 2016-07-20 | 2016-09-02 | ALL UKALL2011 TRIAL | Y | null | 210007627 | UKALL 2011 |
| 210038956 | 210005853 | 1.72 | 105 | Curative (C) | 2016-06-27 | 2016-08-01 | Temozolomide + RT | N | null | 210007896 | TEMOZOLOMIDE + RT |
| 210038957 | 210032911 | 1.63 | 71.9 | Palliative (P) | 2018-01-16 | 2018-01-23 | IBRUTINIB | N | N | 210008484 | IBRUTINIB |
| 210038958 | 210018597 | 1.78 | 0 | Curative (C) | 2017-04-23 | 2017-04-23 | Alemtuzumab | N | N | 210010917 | ALEMTUZUMAB |
| 210038959 | 210024843 | 1.73 | 70 | Curative (C) | 2020-06-05 | 2020-08-23 | Temozolomide 200mg/m2 | N | null | 210002777 | TEMOZOLOMIDE |
| 210038960 | 210017531 | 1.48 | null | Curative (C) | 2019-12-26 | 2020-01-12 | ALL UKALL2011 Maintenance A1 | Y | null | 210004002 | UKALL2011 |
| 210038962 | 210017930 | null | 52.42 | Curative (C) | 2016-08-31 | 2016-10-05 | ALL UKALL2011 Consolidation A | N | N | 210007627 | UKALL 2011 |
| 210038963 | 210005853 | null | 16 | Curative (C) | 2016-03-29 | 2016-08-01 | ALL UKALL2011 TRIAL | 01 | null | 210007896 | UKALL 2011 |
| 210038964 | 210006726 | 1.64 | 52.9 | Curative (C) | 2018-04-21 | 2018-05-12 | Venetoclax | 02 | N | 210010917 | VENETOCLAX |
| 210038965 | 210024843 | 1.56 | null | Curative (C) | 2020-07-07 | 2020-10-14 | ALL UKALL2011 Del Int A Pt1 (PAsp) | Y | N | 210002777 | UKALL2011 |
| 210038967 | 210017930 | null | 57.1 | Curative (C) | 2016-10-04 | 2016-12-14 | ALL UKALL2011 TRIAL | Y | N | 210007627 | UKALL 2011 |
| 210038968 | 210005853 | 1.58 | 48 | Curative (C) | 2016-03-27 | 2016-09-11 | Rituximab (Maintenance) | null | null | 210007896 | RITUXIMAB |
| 210038969 | 210006727 | 1.66 | 78.6 | Palliative (P) | 2018-07-28 | 2018-07-29 | IBRUTINIB | 02 | N | 210010917 | IBRUTINIB |
| 210038970 | 210024843 | 1.1 | 17.1 | Curative (C) | 2020-07-20 | 2020-12-25 | ALL UKALL2011 Del Int B Pt1 (PAsp) | Y | N | 210002777 | UKALL2011 |
| 210038972 | 210017930 | 0 | 22.25 | Curative (C) | 2016-11-09 | 2017-02-15 | ALL UKALL2011 Std Int Maint B | Y | N | 210007627 | UKALL 2011 |
| 210038973 | 210024843 | null | 21 | Curative (C) | 2018-06-13 | 2021-01-05 | ALL UKALL2011 (ProtM-A) C PegAsp | Y | N | 210002777 | UKALL2011 |
| 210038975 | 210017930 | null | null | Curative (C) | 2016-03-27 | 2017-03-26 | ALL UKALL2011 TRIAL | Y | N | 210007627 | UKALL 2011 |
| 210038976 | 210024843 | null | null | Curative (C) | 2019-11-20 | 2021-01-05 | ALL UKALL2011 (ProtM-A) C PegAsp | Y | null | 210002777 | UKALL2011 |
| 210038978 | 210017930 | 1.77 | null | Curative (C) | 2016-09-05 | 2017-05-14 | Erwinase (Erwinia Asparaginase) | Y | N | 210007627 | INOTUZUMAB OZOGAMICIN |
| 210038979 | 210024843 | null | 16.3 | Curative (C) | 2020-05-27 | 2021-02-09 | ALL UKALL2011 Del Int C Recon PAsp | Y | null | 210002777 | UKALL2011 |